A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster ModelJakob Kreye, Harald Prüß, S. Momsen Reincke et al.|Cell|2020Cited by 387
Age-Dependent Progression of SARS-CoV-2 Infection in Syrian HamstersNikolaus Osterrieder, Jakob Trimpert, Achim D. Gruber et al.|Viruses|2020Cited by 243
Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19Geraldine Nouailles, Martin Witzenrath, Emanuel Wyler et al.|Nature Communications|2021Cited by 101
The Roborovski Dwarf Hamster Is A Highly Susceptible Model for a Rapid and Fatal Course of SARS-CoV-2 InfectionJakob Trimpert, Nikolaus Osterrieder, Daria Vladimirova et al.|Cell Reports|2020Cited by 100
Epithelial response to IFN‐γ promotes SARS‐CoV‐2 infectionJulian Heuberger, Michael Sigal, Jakob Trimpert et al.|EMBO Molecular Medicine|2021Cited by 88